National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) collection
The main purpose of the NOPSAD collection is to aggregate standardised jurisdictional data on the number of clients accessing pharmacotherapy for the treatment of opioid dependence, the number of prescribers participating in the delivery of pharmacotherapy treatment, and quantitative information about the prescribing sector. As such, national information on pharmacotherapy can be reported.
from 30/6/2004 to 30/6/2022
National and State
Summary tables published in electronic form
Client specified tables on request which may be subject to data provider approval (charges apply).
Unit records are not available.
The collection covers the provision of opioid pharmacotherapy treatment, the practitioners who prescribe the treatment, the dosing sites who dispense the pharmacotherapy drugs, and the clients receiving the opioid pharmacotherapy treatment. The following pharmacotherapies are currently recommended for the treatment of opioid dependency:
Methadone hydrochlorideMethadone Syrup®
Biodone Forte ®
buprenorphine as long acting injections (Buvidal® and Sublocade®).
Metadata information and data quality statement (DQS)